Skip to main content

Table 4 Univariate and multivariate analyses for lung cancer patients on overall survival in the GSE30219

From: CLEC3B as a potential diagnostic and prognostic biomarker in lung cancer and association with the immune microenvironment

Variable

Univariate analysis

Multivariate analysis

HR (95% CI)

p-value

HR (95% CI)

p-value

Age (≤ 55 vs >5 5 years)

1.039 (1.025–1.054)

0.000

1.041 (1.026–1.056)

0.000

Gender

 Female vs male

0.573 (0.360–0.910)

0.018

0.670 (0.419–1.071)

0.094

T stage

 T1 vs T2 vs T3 vs T4

1.625 (1.415-1.866)

0.000

1.311 (1.082–1.590)

0.006

N stage

 N0 vs N1 vs N2 vs N4

1.730 (1.472–2.034)

0.000

1.371 (1.097–1.715)

0.006

M stage

 M0 vs M1

2.718 (1.114–6.631)

0.028

2.432 (0.987–5.997)

0.054

CLEC3B expression

 High vs low

0.565 (0.423–0.753)

0.000

0.789 (0.577–1.077)

0.136

  1. CI, confidence interval; HR, hazard ratio